Company intelligence / Profile preview

Novo Holdings

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Novo Holdings is one of the world’s leading life sciences investors and manages assets for the Novo Nordisk Foundation. It controls major healthcare firms like Novo Nordisk and Novonesis and invests globally across all stages of life science development. In 2024 alone it deployed €1.7 billion into life sciences with over 300 investments since 1999. Its venture arm has seen successful exits including acquisitions by AstraZeneca and Johnson & Johnson based on positive clinical results from its portfolio companies.

Therapeutic areas: EndocrinologyDermatologyOtherOncologyRare DiseasesInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateGene therapyCell therapymRNA-based drugsPeptidesVaccineBispecific monoclonal antibody
Industry: Investors

Partnerships

Invests alongside major pharma/biotech partners via syndicates but no direct R&D partnerships typical for operating biotechs.Portfolio exits/acquisitions have involved AstraZeneca, Johnson & Johnson among others.

Beyond the preview

Go deeper on Novo Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novo Holdings.

Explore the full profile